Abingdon Health Plc (LON:ABDX – Get Free Report)’s stock price dropped 4.8% during mid-day trading on Thursday . The company traded as low as GBX 10 ($0.12) and last traded at GBX 10 ($0.12). Approximately 217,062 shares traded hands during mid-day trading, a decline of 36% from the average daily volume of 337,357 shares. The stock had previously closed at GBX 10.50 ($0.13).
Abingdon Health Stock Performance
The company has a debt-to-equity ratio of 55.57, a current ratio of 1.79 and a quick ratio of 1.96. The stock has a market capitalization of £12.17 million, a PE ratio of -1,000.00 and a beta of 0.13. The stock has a 50 day moving average of GBX 9.08 and a two-hundred day moving average of GBX 9.50.
Abingdon Health Company Profile
Abingdon Health Plc engages in the development, manufacture, and distribution of diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides Abingdon Simply Test, a range of self-tests in the field of fertility, health and well-being, infectious diseases, and drug testing; PCRD and PCRD FLEX, are nucleic acid lateral flow tests, which are used for rapid readouts post isothermal amplification; and 2019-nCoV Antigen Test, a rapid lateral flow test for the qualitative detection of antigens to SARS-CoV-2, as well as plant health tests; and nucleic acid lateral flow immunoassays.
Read More
- Five stocks we like better than Abingdon Health
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- MarketBeat Week in Review – 4/22 – 4/26
- NYSE Stocks Give Investors a Variety of Quality Options
- 3 Stocks Leading the U.S. Agriculture Comeback
- 3 Small Caps With Big Return Potential
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
